MDGL · Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

1001 Conshohocken State Road, West Conshohocken, PA, 19428, United States
Biotechnology
Healthcare

Market Cap

9.803B

52 Wk Range

$353.54 - $615.00

Previous Close

$421.99

Open

$420.86

Volume

634,340

Day Range

$393.30 - $425.16

Enterprise Value

9.196B

Cash

961M

Avg Qtr Burn

N/A

Insider Ownership

5.80%

Institutional Own.

97.95%

Qtr Updated

Sep 30th 2026